Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-01-05

AUTHORS

C Dive, R A Smith, E Garner, T Ward, S St George-Smith, F Campbell, W Greenhalf, P Ghaneh, J P Neoptolemos

ABSTRACT

Background:Enzyme-linked immunoassays of full-length (M65) and/or caspase-cleaved (M30) cytokeratin 18 (CK18) released from epithelial cells undergoing necrosis and/or apoptosis, respectively, may have prognostic or predictive biomarker utility in a range of solid tumour types. Characterisation of baseline levels of circulating full length and cleaved CK18 specifically in patients with pancreatic cancer.Methods:Plasma samples from 103 patients with pancreatic cancer stored at −80 °C were assayed for M65 and M30 levels. The median (inter-quartile range (IQR)) duration of plasma storage was 34 (23–57) months. Patients with metastatic disease (n=19) were found to have greater median (IQR) M65 levels (1145 (739–1698) U l−1) compared with the locally advanced (n=20; 748 (406–1150) U l−1) and resected (n=64; 612 (331–987) U l−1) patients (P=0.002). Elevated M65 levels were associated with poorer overall survival on univariate (P<0.001) but not multivariate (P=0.202) analysis. M65 concentrations also exhibited significant associations with concurrent serum–bilirubin levels (P<0.001) and the duration of plasma storage (P<0.001).Conclusions:Baseline plasma CK18 levels in pancreatic cancer are affected by the presence of obstructive jaundice and prolonged plasma storage. Clinical biomarker studies utilising serial CK18 levels are warranted in pancreatic cancer, provided consideration is given to these potentially confounding factors. More... »

PAGES

577-582

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6605494

DOI

http://dx.doi.org/10.1038/sj.bjc.6605494

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049468358

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20051949


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CA-19-9 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme-Linked Immunosorbent Assay", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Keratin-18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Necrosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK", 
          "id": "http://www.grid.ac/institutes/grid.5379.8", 
          "name": [
            "Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dive", 
        "givenName": "C", 
        "id": "sg:person.01224224677.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224224677.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "R A", 
        "id": "sg:person.014067200621.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014067200621.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garner", 
        "givenName": "E", 
        "id": "sg:person.014272237217.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014272237217.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK", 
          "id": "http://www.grid.ac/institutes/grid.5379.8", 
          "name": [
            "Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ward", 
        "givenName": "T", 
        "id": "sg:person.0713326752.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713326752.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK", 
          "id": "http://www.grid.ac/institutes/grid.5379.8", 
          "name": [
            "Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "George-Smith", 
        "givenName": "S St", 
        "id": "sg:person.01264066631.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264066631.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Royal Liverpool University Hospital, Prescot St, Liverpool L7 8XP, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Department of Pathology, Royal Liverpool University Hospital, Prescot St, Liverpool L7 8XP, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Campbell", 
        "givenName": "F", 
        "id": "sg:person.0646035141.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646035141.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Greenhalf", 
        "givenName": "W", 
        "id": "sg:person.01116776343.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116776343.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ghaneh", 
        "givenName": "P", 
        "id": "sg:person.07372440237.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Neoptolemos", 
        "givenName": "J P", 
        "id": "sg:person.0750565077.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750565077.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00280-007-0437-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009637575", 
          "https://doi.org/10.1007/s00280-007-0437-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048363663", 
          "https://doi.org/10.1038/sj.bjc.6602363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048568465", 
          "https://doi.org/10.1038/nrc2066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603129", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046268399", 
          "https://doi.org/10.1038/sj.bjc.6603129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016470081", 
          "https://doi.org/10.1038/sj.bjc.6605175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-9-88", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036560706", 
          "https://doi.org/10.1186/1471-2407-9-88"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-01-05", 
    "datePublishedReg": "2010-01-05", 
    "description": "Background:Enzyme-linked immunoassays of full-length (M65) and/or caspase-cleaved (M30) cytokeratin 18 (CK18) released from epithelial cells undergoing necrosis and/or apoptosis, respectively, may have prognostic or predictive biomarker utility in a range of solid tumour types. Characterisation of baseline levels of circulating full length and cleaved CK18 specifically in patients with pancreatic cancer.Methods:Plasma samples from 103 patients with pancreatic cancer stored at \u221280\u2009\u00b0C were assayed for M65 and M30 levels. The median (inter-quartile range (IQR)) duration of plasma storage was 34 (23\u201357) months. Patients with metastatic disease (n=19) were found to have greater median (IQR) M65 levels (1145 (739\u20131698)\u2009U\u2009l\u22121) compared with the locally advanced (n=20; 748 (406\u20131150)\u2009U\u2009l\u22121) and resected (n=64; 612 (331\u2013987)\u2009U\u2009l\u22121) patients (P=0.002). Elevated M65 levels were associated with poorer overall survival on univariate (P<0.001) but not multivariate (P=0.202) analysis. M65 concentrations also exhibited significant associations with concurrent serum\u2013bilirubin levels (P<0.001) and the duration of plasma storage (P<0.001).Conclusions:Baseline plasma CK18 levels in pancreatic cancer are affected by the presence of obstructive jaundice and prolonged plasma storage. Clinical biomarker studies utilising serial CK18 levels are warranted in pancreatic cancer, provided consideration is given to these potentially confounding factors.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6605494", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "102"
      }
    ], 
    "keywords": [
      "pancreatic cancer", 
      "M65 levels", 
      "CK18 levels", 
      "cytokeratin 18", 
      "poor overall survival", 
      "serum bilirubin levels", 
      "solid tumor types", 
      "median duration", 
      "metastatic disease", 
      "overall survival", 
      "obstructive jaundice", 
      "clinical biomarker studies", 
      "M30 levels", 
      "biomarker utility", 
      "tumor types", 
      "baseline levels", 
      "patients", 
      "confounding factors", 
      "significant association", 
      "cancer", 
      "biomarker studies", 
      "plasma storage", 
      "epithelial cells", 
      "plasma samples", 
      "duration", 
      "jaundice", 
      "levels", 
      "necrosis", 
      "CK18", 
      "disease", 
      "M65", 
      "months", 
      "univariate", 
      "biomarkers", 
      "survival", 
      "apoptosis", 
      "full length", 
      "immunoassay", 
      "association", 
      "cells", 
      "caspases", 
      "factors", 
      "study", 
      "utility", 
      "enzyme", 
      "presence", 
      "concentration", 
      "use", 
      "samples", 
      "consideration", 
      "types", 
      "analysis", 
      "length", 
      "range", 
      "storage", 
      "characterisation"
    ], 
    "name": "Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer", 
    "pagination": "577-582", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049468358"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6605494"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20051949"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6605494", 
      "https://app.dimensions.ai/details/publication/pub.1049468358"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_528.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6605494"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605494'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605494'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605494'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605494'


 

This table displays all metadata directly associated to this object as RDF triples.

250 TRIPLES      21 PREDICATES      99 URIs      85 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6605494 schema:about N090ac7da82964c208c3b84b268498c4c
2 N1890d88cedfc4d8c886d944a81d8dc95
3 N3efe09cac3174a0bbeefe5cb14e81a11
4 N7c61b82b19ee46b2ab60162c038b84e3
5 N851b1a10ada3483d8e4270db52b88bc7
6 Nae6a87f22be143df88a1a7006f56525e
7 Nbf25249e02e74ab68de5b8039edb4dcb
8 Nc8a0e9a12daf44319989507d48ed49c1
9 Nddb6b57ab9db4260b8aff15dd6bb727c
10 Ne1ec5b49edfd48d5a0530366f1d6d099
11 Nf6804a6002d14689a33b203ef8751f31
12 Nf9e19626b253423e89bd9318caeba8b7
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author Na7799be1fd8b4271a587c0327ce7980a
16 schema:citation sg:pub.10.1007/s00280-007-0437-4
17 sg:pub.10.1038/nrc2066
18 sg:pub.10.1038/sj.bjc.6602363
19 sg:pub.10.1038/sj.bjc.6603129
20 sg:pub.10.1038/sj.bjc.6605175
21 sg:pub.10.1186/1471-2407-9-88
22 schema:datePublished 2010-01-05
23 schema:datePublishedReg 2010-01-05
24 schema:description Background:Enzyme-linked immunoassays of full-length (M65) and/or caspase-cleaved (M30) cytokeratin 18 (CK18) released from epithelial cells undergoing necrosis and/or apoptosis, respectively, may have prognostic or predictive biomarker utility in a range of solid tumour types. Characterisation of baseline levels of circulating full length and cleaved CK18 specifically in patients with pancreatic cancer.Methods:Plasma samples from 103 patients with pancreatic cancer stored at −80 °C were assayed for M65 and M30 levels. The median (inter-quartile range (IQR)) duration of plasma storage was 34 (23–57) months. Patients with metastatic disease (n=19) were found to have greater median (IQR) M65 levels (1145 (739–1698) U l−1) compared with the locally advanced (n=20; 748 (406–1150) U l−1) and resected (n=64; 612 (331–987) U l−1) patients (P=0.002). Elevated M65 levels were associated with poorer overall survival on univariate (P<0.001) but not multivariate (P=0.202) analysis. M65 concentrations also exhibited significant associations with concurrent serum–bilirubin levels (P<0.001) and the duration of plasma storage (P<0.001).Conclusions:Baseline plasma CK18 levels in pancreatic cancer are affected by the presence of obstructive jaundice and prolonged plasma storage. Clinical biomarker studies utilising serial CK18 levels are warranted in pancreatic cancer, provided consideration is given to these potentially confounding factors.
25 schema:genre article
26 schema:isAccessibleForFree true
27 schema:isPartOf N605666fe69a046babbb3c07f05313e44
28 N6105de66c8014d3eb0ca254a4a7d2c02
29 sg:journal.1017082
30 schema:keywords CK18
31 CK18 levels
32 M30 levels
33 M65
34 M65 levels
35 analysis
36 apoptosis
37 association
38 baseline levels
39 biomarker studies
40 biomarker utility
41 biomarkers
42 cancer
43 caspases
44 cells
45 characterisation
46 clinical biomarker studies
47 concentration
48 confounding factors
49 consideration
50 cytokeratin 18
51 disease
52 duration
53 enzyme
54 epithelial cells
55 factors
56 full length
57 immunoassay
58 jaundice
59 length
60 levels
61 median duration
62 metastatic disease
63 months
64 necrosis
65 obstructive jaundice
66 overall survival
67 pancreatic cancer
68 patients
69 plasma samples
70 plasma storage
71 poor overall survival
72 presence
73 range
74 samples
75 serum bilirubin levels
76 significant association
77 solid tumor types
78 storage
79 study
80 survival
81 tumor types
82 types
83 univariate
84 use
85 utility
86 schema:name Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer
87 schema:pagination 577-582
88 schema:productId N119a4079591746e7820f4651f842988a
89 N7e1a77bce16e4af99256fd903a59d2d9
90 Nc8be57c698ff408b816114816556eff1
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049468358
92 https://doi.org/10.1038/sj.bjc.6605494
93 schema:sdDatePublished 2022-09-02T15:54
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher N2b6df68bf11541ffbdfcbbc449f4a0f6
96 schema:url https://doi.org/10.1038/sj.bjc.6605494
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N04f26bd5624745cf8564485bf4545381 rdf:first sg:person.0713326752.55
101 rdf:rest N389b5ad47182420994572e4c01ce0f26
102 N090ac7da82964c208c3b84b268498c4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Middle Aged
104 rdf:type schema:DefinedTerm
105 N10db78161dbd4185912b676e52ca15c2 rdf:first sg:person.0750565077.18
106 rdf:rest rdf:nil
107 N119a4079591746e7820f4651f842988a schema:name doi
108 schema:value 10.1038/sj.bjc.6605494
109 rdf:type schema:PropertyValue
110 N1890d88cedfc4d8c886d944a81d8dc95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Humans
112 rdf:type schema:DefinedTerm
113 N2b6df68bf11541ffbdfcbbc449f4a0f6 schema:name Springer Nature - SN SciGraph project
114 rdf:type schema:Organization
115 N33bda5bef2864c53982f868755c522db rdf:first sg:person.07372440237.86
116 rdf:rest N10db78161dbd4185912b676e52ca15c2
117 N35223b5ec4ca448184c1edc209a92143 rdf:first sg:person.014272237217.90
118 rdf:rest N04f26bd5624745cf8564485bf4545381
119 N389b5ad47182420994572e4c01ce0f26 rdf:first sg:person.01264066631.22
120 rdf:rest N843e8036c39f47538567935cc05348d2
121 N3efe09cac3174a0bbeefe5cb14e81a11 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Necrosis
123 rdf:type schema:DefinedTerm
124 N605666fe69a046babbb3c07f05313e44 schema:volumeNumber 102
125 rdf:type schema:PublicationVolume
126 N6105de66c8014d3eb0ca254a4a7d2c02 schema:issueNumber 3
127 rdf:type schema:PublicationIssue
128 N7c61b82b19ee46b2ab60162c038b84e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Apoptosis
130 rdf:type schema:DefinedTerm
131 N7e1a77bce16e4af99256fd903a59d2d9 schema:name pubmed_id
132 schema:value 20051949
133 rdf:type schema:PropertyValue
134 N843e8036c39f47538567935cc05348d2 rdf:first sg:person.0646035141.16
135 rdf:rest Nfff969129bd54110adf4bbea8ed92c63
136 N851b1a10ada3483d8e4270db52b88bc7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Enzyme-Linked Immunosorbent Assay
138 rdf:type schema:DefinedTerm
139 Na7799be1fd8b4271a587c0327ce7980a rdf:first sg:person.01224224677.10
140 rdf:rest Nafc9e1962d08492995120eef00339352
141 Nae6a87f22be143df88a1a7006f56525e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Female
143 rdf:type schema:DefinedTerm
144 Nafc9e1962d08492995120eef00339352 rdf:first sg:person.014067200621.05
145 rdf:rest N35223b5ec4ca448184c1edc209a92143
146 Nbf25249e02e74ab68de5b8039edb4dcb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Pancreatic Neoplasms
148 rdf:type schema:DefinedTerm
149 Nc8a0e9a12daf44319989507d48ed49c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name CA-19-9 Antigen
151 rdf:type schema:DefinedTerm
152 Nc8be57c698ff408b816114816556eff1 schema:name dimensions_id
153 schema:value pub.1049468358
154 rdf:type schema:PropertyValue
155 Nddb6b57ab9db4260b8aff15dd6bb727c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Aged
157 rdf:type schema:DefinedTerm
158 Ne1ec5b49edfd48d5a0530366f1d6d099 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Biomarkers, Tumor
160 rdf:type schema:DefinedTerm
161 Nf6804a6002d14689a33b203ef8751f31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Keratin-18
163 rdf:type schema:DefinedTerm
164 Nf9e19626b253423e89bd9318caeba8b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Male
166 rdf:type schema:DefinedTerm
167 Nfff969129bd54110adf4bbea8ed92c63 rdf:first sg:person.01116776343.06
168 rdf:rest N33bda5bef2864c53982f868755c522db
169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
170 schema:name Medical and Health Sciences
171 rdf:type schema:DefinedTerm
172 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
173 schema:name Oncology and Carcinogenesis
174 rdf:type schema:DefinedTerm
175 sg:journal.1017082 schema:issn 0007-0920
176 1532-1827
177 schema:name British Journal of Cancer
178 schema:publisher Springer Nature
179 rdf:type schema:Periodical
180 sg:person.01116776343.06 schema:affiliation grid-institutes:grid.415970.e
181 schema:familyName Greenhalf
182 schema:givenName W
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116776343.06
184 rdf:type schema:Person
185 sg:person.01224224677.10 schema:affiliation grid-institutes:grid.5379.8
186 schema:familyName Dive
187 schema:givenName C
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224224677.10
189 rdf:type schema:Person
190 sg:person.01264066631.22 schema:affiliation grid-institutes:grid.5379.8
191 schema:familyName George-Smith
192 schema:givenName S St
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264066631.22
194 rdf:type schema:Person
195 sg:person.014067200621.05 schema:affiliation grid-institutes:grid.415970.e
196 schema:familyName Smith
197 schema:givenName R A
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014067200621.05
199 rdf:type schema:Person
200 sg:person.014272237217.90 schema:affiliation grid-institutes:grid.415970.e
201 schema:familyName Garner
202 schema:givenName E
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014272237217.90
204 rdf:type schema:Person
205 sg:person.0646035141.16 schema:affiliation grid-institutes:grid.415970.e
206 schema:familyName Campbell
207 schema:givenName F
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646035141.16
209 rdf:type schema:Person
210 sg:person.0713326752.55 schema:affiliation grid-institutes:grid.5379.8
211 schema:familyName Ward
212 schema:givenName T
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713326752.55
214 rdf:type schema:Person
215 sg:person.07372440237.86 schema:affiliation grid-institutes:grid.415970.e
216 schema:familyName Ghaneh
217 schema:givenName P
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86
219 rdf:type schema:Person
220 sg:person.0750565077.18 schema:affiliation grid-institutes:grid.415970.e
221 schema:familyName Neoptolemos
222 schema:givenName J P
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750565077.18
224 rdf:type schema:Person
225 sg:pub.10.1007/s00280-007-0437-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009637575
226 https://doi.org/10.1007/s00280-007-0437-4
227 rdf:type schema:CreativeWork
228 sg:pub.10.1038/nrc2066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048568465
229 https://doi.org/10.1038/nrc2066
230 rdf:type schema:CreativeWork
231 sg:pub.10.1038/sj.bjc.6602363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048363663
232 https://doi.org/10.1038/sj.bjc.6602363
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/sj.bjc.6603129 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046268399
235 https://doi.org/10.1038/sj.bjc.6603129
236 rdf:type schema:CreativeWork
237 sg:pub.10.1038/sj.bjc.6605175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016470081
238 https://doi.org/10.1038/sj.bjc.6605175
239 rdf:type schema:CreativeWork
240 sg:pub.10.1186/1471-2407-9-88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036560706
241 https://doi.org/10.1186/1471-2407-9-88
242 rdf:type schema:CreativeWork
243 grid-institutes:grid.415970.e schema:alternateName Department of Pathology, Royal Liverpool University Hospital, Prescot St, Liverpool L7 8XP, UK
244 Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK
245 schema:name Department of Pathology, Royal Liverpool University Hospital, Prescot St, Liverpool L7 8XP, UK
246 Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK
247 rdf:type schema:Organization
248 grid-institutes:grid.5379.8 schema:alternateName Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK
249 schema:name Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK
250 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...